Automated Clinical Pathway for Inflammatory Bowel Disease Care
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT07167836
- Status
- Enrolling By Invitation
Conditions
- Inflammatory Bowel Disease
- Inflammatory Bowel Disease (IBD)
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Electronic medical record-based care pathway — OTHERParticipants will undergo initial automated risk stratification to direct tailored follow-up intervals. If exceeding the maximum time interval, participants in the intervention arm will be contacted by scheduling personnel using a standardized protocol to schedule a follow-up visit. In contrast, patients in the control arm who are overdue will not be made known to any staff and will not be proactively contacted, instead continuing to be managed according to standard of care. To maximize generalizability and understanding among staff and patients, risk stratification will be based on inflammatory bowel disease medication use.
Study Details
Pragmatic randomized controlled trial to evaluate the effect of an electronic medical record-based tool on improving on-time follow up and its effects on inflammatory bowel disease outcomes
Key Dates
- Start date
- Dec 12, 2025
- Status verified
- Dec 2025
- Primary completion
- Dec 13, 2026
- Completion
- Dec 13, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Care pathway armUse of an electronic medical record-based, risk-stratified tool that automates the identification of patients who are overdue for follow up and facilitates a proactive scheduling plan
- No Intervention: Usual careStandard disease management, monitoring, and follow-up as directed by clinical team
Primary Outcome Measure
Proportion of days overdue for completion of clinical follow up [ Time Frame: 12 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UT Southwestern | Dallas | Texas | 75390 | - |
Find similar trials in Dallas, TX
By research site
Related Studies
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel DiseasePHASE2 · Recruiting · Mirador Therapeutics, Inc. · Birmingham, Alabama
- Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel DiseaseRecruiting · VA Office of Research and Development · Decatur, Georgia